Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- A person (or their legal representative) must be able to sign and date a consent form agreeing to take part.
- People who are willing to follow the study procedures and take part in the full research process.
- Adults aged 18 or older of any sex, whether they are patients or healthy volunteers.
- Patients with a suspected or confirmed diagnosis of certain cancers — such as pancreatic cancer, ovarian cancer, or lung adenocarcinoma — supported by evidence such as blood tumour markers, imaging scans (ultrasound, CT, MRI, etc.), or tissue biopsy results, and who are in generally good health.
- People whose results from specific laboratory tests meet the study's requirements (confirm with trial site for exact details).
- Women who could become pregnant must have been using contraception for at least one month before the screening visit, and must commit to using contraception throughout the study and for a set period after it ends.
- People who meet any additional entry criteria set by the trial (confirm with trial site for details).
Who may not be able to join:
- People who are unable to complete a PET/MR or PET/CT scan — for example, those who cannot lie still, or who experience claustrophobia or fear of radiation.
- People who have other existing health conditions alongside the main condition (confirm with trial site for details).
- People with a known allergic reaction to the imaging agents or other ingredients used in this study, or whose fasting blood sugar level is above 11.0 mmol/L before receiving the 18F-FDG imaging injection.
- People with a history of substance or drug misuse.
- People the trial investigators consider unlikely to follow the study requirements.
- People who are currently pregnant or breastfeeding.
- People with any other factors that the trial team considers would make participation unsuitable (confirm with trial site for details).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaoli Lan, PhD, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phone: 0086-027-83692633
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Visual and standardized uptake values assessment of lesions and biodistribution
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.